Ziopharm: Key Oncology Catalyst Approaching
Filed under: drug treatment news 2011
Darinaparsin is the company's unique organic arsenic compound, which is being investigated for its potential in treating lymphoma (ZIOPHARM is investigating the drug's role in treating other cancers as well). ZIOPHARM is quick to point out … The …
Read more on Seeking Alpha
Diabetes and Social Media: Helping Patients or Drug Companies?
Filed under: drug treatment news 2011
For people living with diabetes — about 26 million Americans — online communities have provided a place to share experiences and treatment information. Drug companies have taken notice and are reaching out directly to patients via social media.
Read more on DrugWatch.com
Active Biotech and Ipsen announce completion of recruitment of tasquinimod …
Filed under: drug treatment news 2011
Lund (Sweden) and Paris (France), December 10, 2012, Active Biotech (NASDAQ OMX NORDIC: ACTI) and Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the Phase III clinical trial for tasquinimod, a novel compound for the treatment of prostate cancer …
Read more on Reuters